查詢結果分析
相關文獻
- Prognostic Evaluation in Supratentorial Astrocytic Tumors Using P53, Epidermal Growth Factor Receptor, C-Erb B-2 Immunostaining
- 成人低惡性度顱內星狀細胞瘤之術後放射治療
- Hypothalamic Juvenile Pilocytic Astrocytoma Presenting with Intracerebral Hemorrhage
- The Prognostic Significance of Pathologic Characteristics of Breast Cancer Patients in Taiwan
- 以免疫組織化學法則測定膀胱移行上皮癌組織胚胎抗原(CEA)在臨床病理的相關性
- Holocord Intramedullary Spinal Cord Astrocytoma:Report of One Case
- Palliative Radiotherapy for Synchronous Brain Metastases from Lung Cancer
- Prognostic Analysis in Patients of Lung Cancer with Brain Metastasis Under Surgical Removal
- Impact of Nutritional Status on the Survival of Lung Cancer Patients
- 腦中風患者其不同腦病變位置與運動功能之相關性
頁籤選單縮合
題名 | Prognostic Evaluation in Supratentorial Astrocytic Tumors Using P53, Epidermal Growth Factor Receptor, C-Erb B-2 Immunostaining=以p53、上皮生長因子受器及c-erbB-2免疫染色評估天幕上區星狀細胞瘤患者的預後 |
---|---|
作者 | 黃旭霖; 洪義人; 蔡志仁; 林相如; 洪純隆; Hwang, Shiuh-lin; Hong, Yi-ren; Chai, Chee-yin; Lin, Hsiang-ju; Howng, Shen-long; |
期刊 | The Kaohsiung Journal of Medical Sciences |
出版日期 | 19981000 |
卷期 | 14:10 1998.10[民87.10] |
頁次 | 頁607-615 |
分類號 | 415.1157 |
語文 | eng |
關鍵詞 | 星狀細胞瘤; 組織病理學; 預後; Astrocytoma; Histopathology; Prognosis; |
中文摘要 | 分子病理學對於預測腫瘤患者預後扮演著重要的角色,其中以p53、上皮生長因子 受器(epidermal growth factor receptor)和c-erbB-2的研究較為廣泛。本研究分析六個 預後因子(年齡、性別、組織惡性度分級、p53、上皮生長因子受器、c-erbB-2)對於天幕上 區星狀細胞瘤患者預後的影響。本研究收集37例星狀細胞瘤,包括9例分化良好星狀細胞瘤 (WHO第2級),19例分化不良星狀細胞瘤(WHO第3級),和9例最惡性的多形性神經膠母細胞瘤( WHO第4級)。在單變項分析中,對預後無統計學意義者包括:性別(p=0.2188),年齡(p=0.5530), p53免疫染色(p=0.2194),和c-erbB-2蛋白免疫染色(p=0.4203);而組織惡性度分級 (p=0.0049)與上皮生長因子受器免疫染色(p=0.0284)對預後評估有統計學上的意義。在多變 項分析中,只有組織惡性度分級表現出有意義的獨立變項(p=0.0152)。在WHO第2級和第3級星 星狀細胞瘤中,p53或上皮生長因子受器的表現和預後不好有關。在多形性神經膠母細胞瘤中 ,p53和預後不好有關。本研究顯示,組織惡性度分級是天幕上區星狀細胞瘤預後預測最好的 指標。p53或上皮生長因子受器和預後有關,但無統計學的意義。 |
英文摘要 | Molecular pathology may play an important role in predicting tumor prognosis,particularly p53,epidermal growth factor receptor(EGFR),and c-erbB-2. We investigated six variables (age,sex,histopathological grade,p53,EGFR, and c-erbB-2)to identify the role of such factors in predicting the outcome of patients with supratentorial astrocytic tumors. Thirty-seven tumors were studied including 9 well-differentiated astrocytomas(WHO grade 2),19 anaplastic astrocytomas(WHO grade 3),and 9 glioblastomas multiforme (WHO grade 4).In univariate analysis,no statistical significance was found for the prognostic value of the sex (p=0.2188),age(p=0.5530),p53 immunostain (p=0.2194),and c-erbB-2 immunostain (p=0.4203).A significant correlation with the prognosis was found with respect to the hsitopathological grade (p=0.0049)and EGFR expression (p=0.0284).In multivariate analysis,the histopathological grade was shown to be significant independent variable (p=0.0152).In WHO grade 2 and 3 astrocytomas, expression of p53 or EGFR was associated with poorer patient outcome.In glioblastomas, expression of p53 was also associated with poorer prognosis. Our studies suggested that conventional histological assessment of supratentorial astrocytic tumors remains the best guide to prognosis. Although no statistical significance was found between the immunostaions and survival in variant grades of astrocytomas,there was a trend between p53 or EGFR proteins expression and the decrease of survival time. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。